April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of complications stemm
Cardio-oncology
This channel includes news and new technology innovations about cardio oncology, the subspeciality of monitoring, preventing and treating cardiovascular damage caused by cancer treatments such as chemotherapy and radiation therapy. Chemo and radiation can damage or kill cardiac muscle cells, which can result in reduced cardiac pumping capacity. The speciality of cardio-oncology monitors cardiac performance with a baseline echocardiogram and followup imaging during treatments to ensure the heart is not damaged.
-
-
Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital.
-
Interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University, at the American Society of Echocardiography (ASE) 2016 annual meeting. Asch...
-
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat cancer patients for the second leading cause of death among cancer survivors — cardiovascular disease brought on by their treatments.
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents.
News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC...
Figure 2: Pulmonary CT angiography of a 68 year old male. The CT scan was obtained 10 days after the onset of COVID-19 symptoms and on the day the patient was transferred to the intensive care unit. Axial CT images (lung windows) (a,b) show peripheral ground-glass opacities (arrow) associated with areas of consolidation in dependent portions of the lung (arrowheads). Interlobular reticulations, bronchiectasis (black arrow) and lung architectural distortion are present. Involvement of the lung volume was estimated to be between 25% and 50%. Coronal CT reformations (mediastinum windows) (c,d) show bilateral lobar and segmental pulmonary embolism (black arrows). Courtesy of RSNA
News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of...
News | Cardio-oncology | July 29, 2019
July 29, 2019 — Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest...
3D Auto RV application image courtesy of Philips Healthcare
Technology | Cardiovascular Ultrasound | July 02, 2019
July 2, 2019 — Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac...
Videos | Cardio-oncology | March 22, 2019
Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been...
News | Cardio-oncology | March 13, 2019
March 13, 2019 — An imaging procedure commonly performed before starting cancer treatment can provide valuable clues...
News | Cardio-oncology | January 03, 2019
January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage,...
News | Cardio-oncology | December 21, 2018
December 21, 2018 — Older adults with cancer are more likely to have had a heart attack or stroke in the months prior...
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of breast cancer treatment, the risk is higher in...
News | Cardiovascular Ultrasound | June 19, 2018
June 19, 2018 — Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging...
News | Cardio-oncology | February 01, 2018
February 1, 2018 — Breast cancer patients may be at increased risk of cardiovascular diseases including heart failure...
News | Cardio-oncology | May 03, 2017
May 3, 2017 — Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College...
News | Cardio-oncology | September 28, 2016
September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for...
Epsilon’s EchoInsight software is used to help evaluate cardiotoxcity due to chemotherapy or radiation therapy.
Feature | Radiation Oncology | September 07, 2016 | By Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat...
Videos | Cardio-oncology | June 30, 2016
Interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health...
News | Cardiovascular Ultrasound | June 17, 2016
June 17, 2016 — Epsilon Imaging Inc. announced a research study was presented at the American Society of...
Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain.
Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat...
News | Oncology Diagnostics | May 06, 2016
May 6, 2016 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus...
News | Cardiovascular Ultrasound | January 27, 2016
January 27, 2016 — Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT)...
Feature | June 24, 2015
June 24, 2015 - A nationwide study published in the Journal of the American College of Cardiology identified current...
